DGHMC
VMD icon

Dalton, Greiner, Hartman, Maher & Co’s Viemed Healthcare VMD Stock Holding History

Dalton, Greiner, Hartman, Maher & Co’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-40,782
Closed -$413K – 125
2021
Q1 		$413K Sell
40,782
-8,250
-17% -$77.7K 0.33% 117
2020
Q4 		$380K Buy
+49,032
New +$431K 0.08% 155

Other funds holding VMD

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Dalton, Greiner, Hartman, Maher & Co's VMD Position: Q2 2021 in Review

Dalton, Greiner, Hartman, Maher & Co sold out of Viemed Healthcare (VMD) in Q2 2021, closing a stake of 40,782 shares — an estimated $413K sold.

Dalton, Greiner, Hartman, Maher & Co first reported a position in VMD in Q4 2020 and held it in 2 quarters. The position peaked at $413K in Q1 2021. 77 funds tracked by Wall St. Rank hold VMD as of Q2 2021.

  • Dalton, Greiner, Hartman, Maher & Co reported no remaining Viemed Healthcare position as of Q2 2021 after selling out during the quarter.
  • Dalton, Greiner, Hartman, Maher & Co sold 40,782 Viemed Healthcare shares in Q2 2021, an estimated $413K.
  • Dalton, Greiner, Hartman, Maher & Co first reported a position in Viemed Healthcare in Q4 2020 and held it in 2 quarters.
  • Dalton, Greiner, Hartman, Maher & Co's Viemed Healthcare position peaked at $413K in Q1 2021.
  • 77 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2021.

Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q2 2021.